FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of general formula (I): (where R1 and R2 may be identical or different, and each is a 1,3-substituted aryl with substituents from group α; R3 stands for any of the following groups: -CO-R4, -CO-O-R4, -CO-NH-R4, -CO-CH2-N(Ra)Rb, -(CH2)m-CO-R5, -(CH2)m-R5, -CO-NH-CO-N(Ra)Rb, -CO-NH-SO2-N(Ra)Rb, -CO-NH-CO-(CH2)m-N(Ra)Rb, or -CO-NH2; R4 stands for a lower alkyl, cycloalkyl, cycloalkyl substituted with 1-3 substituent from group α, lower alkenyl, lower alkynyl, halogen-substituted lower alkyl, hydroxyl-substituted lower alkyl, lower alkoxyalkyl, lower aliphatic acyloxyalkyl or lower alkoxycarbonylalkyl; R5 stands for hydroxyl, -OR4 or -N(Ra)Rb; Rа and Rb may be identical or different, each of them stands for hydrogen, hydroxyl, lower alkoxy group, hydroxyl-substituted lower alkoxyl, hydroxyl-substituted lower alkoxyalkyl, lower alkoxy lower alkoxyalkyl, cyano lower alkyl, cyano lower alkoxyalkyl, carboxy lower alkyl, carboxy lower alkoxyalkyl, aliphatic lower alkoxycarbonyl lower alkoxyalkyl, carbamoyl lower alkyl group, carbamoyl lower alkoxyalkyl, lower aliphatic acylamino lower alkyl, lower aliphatic acylamino lower alkoxyalkyl, lower alkylsulphonylamino lower alkyl, lower alkylsulphanylamino lower alkoxyalkyl, (N-hydroxy-N-methylcarbamoyl) lower alkyl, (N-hydroxy-N-methylcarbamoyl) lower alkoxyalkyl, (N-lower alkoxy-N-methylcarbamoyl) lower alkyl, (N-lower alkoxy-14-methylcarbamoyl) lower alkoxyalkyl or R4, or both, including associated nitrogen, stand for nitrogen-containing heterocyclic group or nitrogen-containing 1-3 substituted heterocyclic group with substituents from group α; m is an integer from 1 to 6; А stands for carbonyl; В stands for straight bond; D stands for oxygen atom; Е stands for С1-С4 alkylene; n is an integer from 1 to 3; and α group is a group of substituents, which consist of halogen atoms, lower alkyls, hydroxy lower alkyls, halogen lower alkyls, carboxy lower alkyls, lower alkoxyls, hydroxy lower alkoxyls, hydroxy lower alkoxyalkyls, lower alkoxycarbonyls, carboxyls, hydroxyls, lower aliphatic acyls, lower aliphatic acylamines, (N-hydroxy-N-methylcarbamoyl) lower alkyls, (N-lower alkoxy-N-methylcarbamoyl) lower alkyls, hydroxy lower aliphatic acylamines, amines, carbamoyls and cyano groups), or pharmacologically suitable salt thereof. Invention also relates to pharmaceutical composition and method for disease prevention and treatment.
EFFECT: preparation of novel biologically active compounds.
18 cl, 117 ex
Title | Year | Author | Number |
---|---|---|---|
PROPANE-1,3-DION DERIVATIVE OR SALT | 2006 |
|
RU2404973C2 |
DERIVATIVES OF SPIROPIPERIDINE, MEDICINAL AGENT, METHOD OF PROPHYLAXIS OR TREATMENT | 1999 |
|
RU2184735C2 |
ACYLATED HETEROALICYCLIC DERIVATIVES, MEDICINAL AGENT SHOWING SELECTIVE ANTAGONISTIC ACTIVITY AGAINST NK-RECEPTORS, METHOD OF PROPHYLAXIS OR TREATMENT OF PATIENTS | 1998 |
|
RU2174122C1 |
SOLUBLE C5aR ANTAGONISTS | 2017 |
|
RU2748260C2 |
DERIVATIVES OF 2,6-QUINOLINYL AND 2,6-NAPHTHYL, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, THEIR USING AS VLA-4 INHIBITORS AND INTERMEDIATE COMPOUNDS | 2003 |
|
RU2315041C2 |
DERIVATIVES OF N-TRIAZOLYLMETHYLPIPERAZINE, METHOD FOR THEIR PREPARING, MEDICINAL AGENT, DERIVATIVES OF PIPERAZINE | 2001 |
|
RU2288918C2 |
CARBOXAMIDE COMPOUNDS AND USING THEM AS CALPAIN INHIBITORS | 2010 |
|
RU2540856C2 |
SUBSTITUTED CYCLOALKENE DERIVATIVES | 2006 |
|
RU2386613C2 |
PRODRUG 1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES | 2003 |
|
RU2357962C2 |
PYRIDOINDOLONE DERIVATIVES SUBSTITUTED IN POSITION 6, THEIR OBTAINING AND APPLICATION IN THERAPY | 2005 |
|
RU2364595C2 |
Authors
Dates
2008-05-10—Published
2005-02-24—Filed